SILVER SPRING, Md., July 20, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic: The FDA reissued an Emergency Use Authorization (EUA) to Quest Diagnostics for its Quest SARS-CoV-2 rRT-PCR test,...
from PR Newswire: https://ift.tt/2E6wsPb
No comments:
Post a Comment